x

Gen1E Lifesciences

Gen1E “Genie” Lifesciences is a cutting-edge Y-Combinator biotech startup that utilizes advanced computational biology approaches to develop cures to some of the most fatal inflammatory diseases present today. Gen1E developed a proprietary p38α kinase inhibitor platform to develop treatments for various inflammatory and age-related diseases, including Acute Respiratory Distress Syndrome (ARDS). GEn1E has a pipeline consisting of numerous programs with strong clinical data and plans to penetrate the $100 billion-dollar inflammatory disease market after FDA approval.

www.gen1elifesci.com


Gen1E Lifesciences